[Antiangiogenic therapy]
- PMID: 9838900
[Antiangiogenic therapy]
Abstract
Tumor vasculature is a promising novel target for anticancer treatment. Natural or synthetic products have been developed, and endogenous inhibitors such as angiostatin have been extensively analyzed. Several inhibitors are currently under investigation, and many compounds are tested in pre-clinical trials. This review provides an overview of the antiangiogenic treatments as well as early clinical result with these agents.
Similar articles
-
Cancer experts offer healthy dose of skepticism toward hype over antiangiogenesis agents.JAMA. 1998 Jun 24;279(24):1936-7. JAMA. 1998. PMID: 9643843 No abstract available.
-
Anticancer drug targets: approaching angiogenesis.J Clin Invest. 1999 Dec;104(11):1497-501. doi: 10.1172/JCI8849. J Clin Invest. 1999. PMID: 10587512 Free PMC article. Review. No abstract available.
-
Angiogenesis and antiangiogenic therapy.Curr Probl Cancer. 2002 Jan-Feb;26(1):1-60. Curr Probl Cancer. 2002. PMID: 11961506 Review. No abstract available.
-
Cancer 'cure' article stirs up hot debate.Nature. 1998 May 14;393(6681):104-5. doi: 10.1038/30072. Nature. 1998. PMID: 9603508 No abstract available.
-
[Research on the endothelium and new therapeutic strategies in tumors and cardiovascular diseases].Recenti Prog Med. 1999 Feb;90(2):64-8. Recenti Prog Med. 1999. PMID: 10208094 Italian. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources